La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Yves Agid And NotAnalyse quantitative

List of bibliographic references

Number of relevant bibliographic references: 235.
Ident.Authors (with country if any)Title
000027 Marie-Laure Welter [France] ; Michael Schüpbach [France, Suisse] ; Virginie Czernecki [France] ; Carine Karachi [France] ; Sara Fernandez-Vidal [France] ; Jean-Louis Golmard [France] ; Giulia Serra [France] ; Soledad Navarro [France] ; Arlette Welaratne [France] ; Andréas Hartmann [France] ; Valérie Mesnage [France] ; Fanny Pineau [France] ; Philippe Cornu [France] ; Bernard Pidoux [France] ; Yulia Worbe [France] ; Panayiotis Zikos [France, Grèce] ; David Grabli [France] ; Damien Galanaud [France] ; Anne-Marie Bonnet [France] ; Hayat Belaid [France] ; Didier Dormont [France] ; Marie Vidailhet [France] ; Luc Mallet [France] ; Jean-Luc Houeto [France] ; Eric Bardinet [France] ; Jerome Yelnik [France] ; Yves Agid [France]Optimal target localization for subthalamic stimulation in patients with Parkinson disease
000301 Jean-Christophe Corvol [France] ; Cécilia Bonnet [France] ; Fanny Charbonnier-Beaupel [France] ; Anne-Marie Bonnet [France] ; Marie-Hélène Fievet [France] ; Agnès Bellanger [France] ; Emmanuel Roze [France] ; Gayané Meliksetyan [France] ; MOUNA BEN DJEBARA [France] ; Andreas Hartmann [France] ; Lucette Lacomblez [France] ; Cédric Vrignaud [France] ; Noël Zahr [France] ; Yves Agid [France] ; Jean Costentin [France] ; Jean-Sébastien Hulot [France] ; Marie Vidailhet [France]The COMT Val158Met Polymorphism Affects the Response to Entacapone in Parkinson's Disease: A Randomized Crossover Clinical Trial
000450 W. M. M. Schüpbach [France, Suisse] ; J.-C. Corvol [France] ; V. Czernecki [France] ; M. B. Djebara [France] ; J.-L. Golmard [France] ; Yves Agid [France] ; A. Hartmann [France]Segmental progression of early untreated Parkinson's disease: a novel approach to clinical rating
000472 Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Cesaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France]Orodispersible Sublingual Piribedil to Abort OFF Episodes: A Single Dose Placebo-Controlled, Randomized, Double-Blind, Cross-Over Study
000481 Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Pierre Pollak [France] ; Yves Agid [France] ; Stig Rehncrona [Suède] ; Jens Volkmann [Allemagne] ; Jaime Kulisevsky [Espagne] ; Jose A. Obeso [Espagne] ; Alberto Albanese [Italie] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Niall P. Quinn [Canada] ; Jans D. Speelman [Pays-Bas] ; Alim L. Benabid [France] ; Valerie Fraix [France] ; Alexandre Mendes [France] ; Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Annalena L. Tornqvist [Suède] ; Ron Ekberg [Suède] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Andres Gironell [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; Anna R. Bentivoglio [Italie] ; Maria F. Contarino [Italie, Pays-Bas] ; Luigi Romito [Italie] ; Massimo Scerrati [Italie] ; Marc Janssens [Pays-Bas] ; Anthony E. Lang [Canada]Long-Term Results of a Multicenter Study on Subthalamic and Pallidal Stimulation in Parkinson's Disease
000490 Peter Redgrave [Royaume-Uni] ; Manuel Rodriguez [Espagne] ; Yoland Smith [États-Unis] ; Maria C. Rodriguez-Oroz [Espagne] ; Stephane Lehericy [France] ; Hagai Bergman [Israël] ; Yves Agid [France] ; Mahlon R. Delong [États-Unis] ; Jose A. Obeso [Espagne]Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease
000511 Richard G. Brown [Royaume-Uni] ; Lucette Lacomblez [France] ; Bernard G. Landwehrmeyer [Allemagne] ; Thomas Bak [Royaume-Uni] ; Ingo Uttner [Allemagne] ; Bruno Dubois [France] ; Yves Agid [France] ; Albert Ludolph [Allemagne] ; Gilbert Bensimon [France] ; Christine Payan [France] ; Nigel P. Leigh [Royaume-Uni]Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy
000549 H. El Otmani [France] ; N. Jodoin [France] ; S. Yaici [France] ; M.-L. Welter [France] ; A.-M. Bonnet [France] ; S. Navarro [France] ; B. Pidoux [France] ; D. Dormont [France] ; P. Cornu [France] ; Yves Agid [France]La stimulation du noyau subthalamique peut-elle révéler un tremblement de repos parkinsonien ?
000571 Pablo Ibanez [France, Royaume-Uni] ; LESAGE [France] ; Sabine Janin [France] ; Ebba Lohmann [France] ; Frank Durif [France] ; Alain Destée [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Simon Heath [France] ; Diana Zelenika [France] ; Yves Agid [France] ; Alexandra Dürr [France] ; Alexis Brice [France]α-Synuclein Gene Rearrangements in Dominantly Inherited Parkinsonism : Frequency, Phenotype, and Mechanisms
000582 Gilbert Bensimon [France] ; Albert Ludolph [Allemagne] ; Yves Agid [France] ; Marie Vidailhet [France] ; Christine Payan [France] ; P. Nigel Leigh [Royaume-Uni]Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders : The NNIPPS Study
000594 Sophie Lavault [France] ; Frederic Bloch [France] ; Jean-Luc Houeto [France] ; Eric Konofal [France] ; Marie-Laure Welter [France] ; Yves Agid [France] ; Isabelle Amulf [France]Periodic Leg Movements and REM Sleep Without Atonia in Parkinson's Disease with Camptocormia
000611 Jens Volkmann [Allemagne] ; Alberto Albanese [Italie] ; Jaime Kulisevsky [Espagne] ; Aana-Lena Tornqvist [Suède] ; Jean-Luc Houeto [France] ; Bernard Pidoux [France] ; Anne-Marie Bonnet [France] ; Alexandre Mendes [France] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Nadege Van Blercom [France] ; JING XIE [France] ; José Obeso [Espagne] ; Maria Cruz Rodriguez-Oroz [Espagne] ; Jurge Guridi [Espagne] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Alexandre A. Gironell [Espagne] ; Juan Molet [Espagne] ; Benta Pascual-Sedano [Espagne] ; Stig Rehncrona [Suède] ; Elena Moro [Canada] ; Anthony C. Lang [Canada] ; Andres M. Lozano [Canada] ; Anna Rita Bentivoglio [Italie] ; Massimo Scerrati [Italie] ; Maria Fiorella Contarino [Pays-Bas] ; Luigi Romito [Italie] ; Marc Janssens [Pays-Bas] ; Yves Agid [France]Long-Term Effects of Pallidal or Subthalamic Deep Brain Stimulation on Quality of Life in Parkinson's Disease
000616 Nathalie Chastan [France] ; MANH CUONG DO [France] ; Fabrice Bonneville [France] ; Frédéric Torny [France] ; Frédéric Bloch [France] ; G. W. Max Westby [France] ; Didier Dormont [France] ; Yves Agid [France] ; Marie-Laure Welter [France]Gait and Balance Disorders in Parkinson's Disease : Impaired Active Braking of the Fall of Centre of Gravity
000620 N. Chastan [France] ; G. W. M. Westby [France] ; J. Yelnik [France] ; E. Bardinet [France] ; M. C. Do [France] ; Yves Agid [France] ; M. L. Welter [France]Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease
000629 Pierre Payoux [France] ; Philippe Remy [France] ; Malika Miloudi [France] ; Jean-Luc Houeto [France] ; Claudio Stadler [France] ; Boulos-Paul Bejjani [France] ; Jérome Yelnik [France] ; Yves Samson [France] ; Olivier Rascol [France] ; Yves Agid [France] ; Philippe Damier [France]Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease
000649 Eric Bardinet [France] ; Manik Bhattacharjee [France] ; Didier Dormont [France] ; Bernard Pidoux [France] ; Grégoire Malandain [France] ; Michael Schüpbach [France] ; Nicholas Ayache [France] ; Philippe Cornu [France] ; Yves Agid [France] ; Jérome Yelnik [France]A three-dimensional histological atlas of the human basal ganglia. II. Atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease : Clinical article
000652 E. Lohmann [France] ; S. Thobois [France] ; S. Lesage [France] ; E. Broussolle [France] ; S. Tezenas Du Montcel [France] ; M.-J. Ribeiro [France] ; P. Remy [France] ; A. Pelissolo [France] ; B. Dubois [France] ; L. Mallet [France] ; P. Pollak [France] ; Yves Agid [France] ; A. Brice [France]A multidisciplinary study of patients with early-onset PD with and without parkin mutations
000788 Ebba Lohmann [France] ; Marie-Laure Welter [France] ; Valérie Fraix [France] ; Paul Krack [France] ; Suzanne Lesage [France] ; Sophie Laine [France] ; Marie-Laure Tanguy [France] ; Jean-Luc Houeto [France] ; Valérie Mesnage [France] ; Pierre Pollak [France] ; Alexandra Durr [France] ; Yves Agid [France] ; Alexis Brice [France]Are Parkin Patients Particularly Suited for Deep-Brain Stimulation?
000791 Virginie Czernecki [France] ; Michael Schüpbach [France, Suisse] ; Sadek Yaici [France] ; Richard Levy [France] ; Eric Bardinet [France] ; Jérome Yelnik [France] ; Bruno Dubois [France] ; Yves Agid [France]Apathy Following Subthalamic Stimulation in Parkinson Disease : A Dopamine Responsive Symptom
000847 Michael Schüpbach [France] ; Ebba Lohmann [France] ; Mathieu Anheim [France] ; Suzanne Lesage [France] ; Virginie Czernecki [France] ; Sadek Yaici [France] ; Yulia Worbe [France] ; Perrine Charles [France] ; Marie-Laure Welter [France] ; Pierre Pollak [France] ; Alexandra Dürr [France] ; Yves Agid [France] ; Alexis Brice [France]Subthalamic nucleus stimulation is efficacious in patients with parkinsonism and LRRK2 mutations
000859 Valérie Cochen De Cock [France] ; Marie Vidailhet [France] ; Smaranda Leu [France] ; Antonio Texeira [France] ; Emmanuelle Apartis [France] ; Alexis Elbaz [France] ; Emmanuel Roze [France] ; Jean Claude Willer [France] ; Jean Philippe Derenne [France] ; Yves Agid [France] ; Isabelle Arnulf [France]Restoration of normal motor control in Parkinson's disease during REM sleep
000869 W. M. M. Schüpbach [France] ; D. Maltete [France] ; J. L. Houeto [France] ; S. Tezenas Du Montcel [France] ; L. Mallet [France] ; M. L. Welter [France] ; M. Gargiulo [France] ; C. Behar [France] ; A. M. Bonnet [France] ; V. Czernecki [France] ; B. Pidoux [France] ; S. Navarro [France] ; D. Dormont [France] ; P. Cornu [France] ; Yves Agid [France]Neurosurgery at an earlier stage of Parkinson disease : A randomized, controlled trial
000874 Michael W. M. Schupbach [France] ; Marie Laure Welter [France] ; Anne Marie Bonnet [France] ; Alexis Elbaz [France] ; Brandon R. Grossardt [États-Unis] ; Valerie Mesnage [France] ; Jean Luc Houeto [France] ; David Maltete [France] ; Luc Mallet [France] ; Walter A. Rocca [États-Unis] ; Alain Mallet [France] ; Yves Agid [France]Mortality in patients with Parkinson's disease treated by stimulation of the subthalamic nucleus
000884 Suzanne Lesage [France] ; Sabine Janin [France] ; Ebba Lohmann [France] ; Anne-Louise Leutenegger [France] ; Laurence Leclere [France] ; Francois Viallet [France] ; Pierre Pollak [France] ; Franck Durif [France] ; Stephane Thobois [France] ; Valérie Layet [France] ; Marie Vidailhet [France] ; Yves Agid [France] ; Alexandra Dürr [France] ; Alexis Brice [France]LRRK2 exon 41 mutations in sporadic parkinson disease in europeans
000891 Jean-Christophe Corvol [France] ; Jean-Baptiste Anzouan-Kacou [France] ; Elodie Fauveau [France] ; Anne-Marie Bonnet [France] ; Bénédicte Lebrun-Vignes [France] ; Camille Girault [France] ; Yves Agid [France] ; Philippe Lechat [France] ; Richard Isnard [France] ; Lucette Lacomblez [France]Heart Valve Regurgitation, Pergolide Use, and Parkinson Disease : An Observational Study and Meta-analysis
000957 Fabien Etchepare [France] ; Sylvie Rozenberg [France] ; Tristan Mirault [France] ; Anne-Marie Bonnet [France] ; Colette Lecorre [France] ; Yves Agid [France] ; Pierre Bourgeois [France] ; Bruno Fautrel [France]Douleurs rachidiennes au cours de la maladie de Parkinson : un problème sous-estimé
000971 Jean-Luc Houeto [France] ; Luc Mallet [France] ; Valérie Mesnage [France] ; Sophie Tezenas Du Montcel [France] ; Cécile Behar [France] ; Marcela Gargiulo [France] ; Frederic Tomy [France] ; Antoine Pelissolo [France] ; Marie-Laure Welter [France] ; Yves Agid [France]Subthalamic stimulation in parkinson disease : Behavior and social adaptation
000985 Claire Ardouin [France] ; Valerie Voon [Canada] ; Yulia Worbe [France] ; Nehman Abouazar [France] ; Virginie Czernecki [France] ; Hassan Hosseini [France] ; Antoine Pelissolo [France] ; Elena Moro [Canada] ; Eugénie Lhommee [France] ; Anthony E. Lang [Canada] ; Yves Agid [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Luc Mallet [France] ; Paul Krack [France]Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation
000986 R. Djaldetti [Israël] ; E. Melamed [Israël] ; F. Bloch [France] ; J. L. Houeto [France] ; S. Tezenas Du Montcel [France] ; F. Bonneville [France] ; F. Etchepare [France] ; M. L. Welter [France] ; S. Rivaud-Pechoux [France] ; V. Hahn-Barma [France] ; T. Maisonobe [France] ; C. Behar [France] ; J. Y. Lazennec [France] ; E. Kurys [France] ; I. Arnulf [France] ; A. M. Bonnet [France] ; Yves Agid [France]Parkinson's disease with camptocormia. Commentary
000991 M. Schüpbach [France] ; M. Gargiulo [France] ; M. L. Welter [France] ; L. Mallet [France] ; C. Behar [France] ; J. L. Houeto [France] ; D. Maltete [France] ; V. Mesnage [France] ; Yves Agid [France]Neurosurgery in Parkinson disease : A distressed mind in a repaired body?
000995 Pablo Ibanez [France] ; Suzanne Lesage [France] ; Ebba Lohmann [France] ; Stéphane Thobois [France] ; Giuseppe De Michele [Italie] ; Michel Borg [France] ; Yves Agid [France] ; Alexandra Dürr [France] ; Alexis Brice [France]Mutational analysis of the PINK I gene in early-onset parkinsonism in Europe and North Africa
000A55 M. Gargiulo [France] ; M. Schupbach [France] ; C. Behar [France] ; M. L. Welter [France] ; D. Maltete [France] ; J.-L Houeto [France] ; L. Mallet [France] ; V. Mesnage [France] ; B. Pillon [France] ; B. Pidoux [France] ; D. Dormont [France] ; P. Cornu [France] ; S. Navarro [France] ; Yves Agid [France]Neurochirurgie de la maladie de Parkinson: conséquences psychologiques et familiales
000A93 W. M. M. Schüpbach [France] ; N. Chastan [France] ; M. L. Welter [France] ; J. L. Houeto [France] ; V. Mesnage [France] ; A. M. Bonnet [France] ; V. Czernecki [France] ; D. Maltete [France] ; A. Hartmann [France] ; L. Mallet [France] ; B. Pidoux [France] ; D. Dormont [France] ; S. Navarro [France] ; P. Cornu [France] ; A. Mallet [France] ; Yves Agid [France]Stimulation of the subthalamic nucleus in Parkinson's disease : a 5 year follow up
000A98 Isabelle Arnulf [France] ; Milagros Merino-Andreu [France] ; Frédéric Bloch [France] ; Eric Konofal [France] ; Marie Vidailhet [France] ; Valérie Cochen [France] ; Jean-Philippe Derenne [France] ; Yves Agid [France]REM Sleep behavior disorder and REM Sleep without atonia in patients with progressive supranuclear palsy
000B06 F. Bonneville [France] ; M. L. Welter [France] ; C. Elie [France] ; S. Tezenas Du Montcel [France] ; D. Hasboun [France] ; C. Menuel [France] ; J. L. Houeto [France] ; A. M. Bonnet [France] ; V. Mesnage [France] ; B. Pidoux [France] ; S. Navarro [France] ; P. Cornu [France] ; Yves Agid [France] ; D. Dormont [France]Parkinson disease, brain volumes, and subthalamic nucleus stimulation
000B23 Suzanne Lesage [France] ; Pablo Ibanez [France] ; Ebba Lohmann [France] ; Pierre Pollak [France] ; Francois Tison [France] ; Myriem Tazir [Algérie] ; Anne-Louise Leutenegger [France] ; Joao Guimaraes [Portugal] ; Anne-Marie Bonnet [France] ; Yves Agid [France] ; Alexandra Durr [France] ; Alexis Brice [France]G2019S LRRK2 mutation in French and North African families with Parkinson's disease
000B35 M. Samuel [Royaume-Uni] ; V. Voon [États-Unis] ; V. Czernecki [France] ; B. Pillon [France] ; J. L. Houeto [France] ; M. L. Welter [France] ; V. Mesnage [France] ; Yves Agid [France] ; B. Dubois [France]Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?. Commentary
000B52 Hans-Joachim Freund [Allemagne] ; M. C. Rodriguez-Oroz [Espagne] ; J. A. Obeso [Espagne] ; A. E. Lang [Canada] ; J.-L. Houeto [France] ; P. Pollak [France] ; S. Rehncrona [France] ; J. Kulisevsky [Espagne] ; A. Albanese [Italie] ; J. Volkmann [Allemagne] ; M. I. Hariz [Royaume-Uni] ; N. P. Quinn [Royaume-Uni] ; J. D. Speelman [Pays-Bas] ; J. Guridi [Espagne] ; I. Zamarbide [Espagne] ; A. Gironell [Espagne] ; J. Molet [Espagne] ; B. Pascual-Sedano [Espagne] ; B. Pidoux [France] ; A. M. Bonnet [France] ; Yves Agid [France] ; J. Xie [France] ; A.-L. Benabid [France] ; A. M. Lozano [Canada] ; J. Saint-Cyr [Canada] ; L. Romito [Italie] ; M. F. Contarino [Italie] ; M. Scerrati [Italie] ; V. Fraix [France] ; N. Van Blercom [France]Bilateral deep brain stimulation in Parkinson's disease : a multicentre study with 4 years follow-up. Commentary
000C06 David Maltete [France] ; Soledad Navarro [France] ; Marie-Laure Welter [France] ; Sabine Roche [France] ; Anne-Marie Bonnet [France] ; Jean-Luc Houeto [France] ; Valérie Mesnage [France] ; Bernard Pidoux [France] ; Didier Dormont [France] ; Philippe Cornu [France] ; Yves Agid [France]Subthalamic stimulation in Parkinson disease: With or without anesthesia?
000C07 Pierre Payoux [France] ; Philippe Remy [France] ; Philipe Damier [France] ; Malika Miloudi [France] ; Isabelle Loubinoux [France] ; Bernard Pidoux [France] ; Véronique Gaura [France] ; Olivier Rascol [France] ; Yves Samson [France] ; Yves Agid [France]Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease
000C33 C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio ; Fabrizio StocchiLevodopa in the treatment of Parkinson's disease: Current controversies
000C35 Didier Dormont [France] ; Kenneth G. Ricciardi [France] ; Dominique Tande [France] ; Karine Parain [France] ; Carole Menuel [France] ; Damien Galanaud [France] ; Soledad Navarro [France] ; Philippe Cornu [France] ; Yves Agid [France] ; Jérome Yelnik [France]Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data
000C49 Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Anne-Marie Bonnet [France] ; Paul-Boulos Bejjani [France] ; Valérie Mesnage [France] ; Didier Dormont [France] ; Soledad Navarro [France] ; Philippe Cornu [France] ; Yves Agid [France] ; Bernard Pidoux [France]Effects of high-frequency Stimulation on subthalamic neuronal activity in parkinsonian patients
000C66 P. Ibanez [France] ; A-M Bonnet [France] ; B. Debarges [France] ; E. Lohmann [France] ; F. Tison [France] ; P. Pollak ; Yves Agid [France] ; A. Durr [France] ; A. Brice [France] ; Andrew Singleton [États-Unis] ; Katrina Gwinn-Hardy [États-Unis]Causal relation between α-synuclein gene duplication and familial Parkinson's. Commentary disease
000C71 P. Ibanez [France] ; E. Lohmann [France] ; P. Pollak [France] ; F. Durif [France] ; C. Tranchant [France] ; Yves Agid [France] ; A. Dürr [France] ; A. Brice [France]Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease
000D21 L. Mallet [France] ; V. Mesnage [France] ; J.-L. Houeto [France] ; A. Pelissolo [France] ; J. Yelnik [France] ; C. Behar [France] ; M. Gargiulo [France] ; M.-L. Welter [France] ; A.-M. Bonnet [France] ; B. Pillon [France] ; P. Cornu [France] ; D. Dormont [France] ; B. Pidoux [France] ; J.-F. Allilaire [France] ; Yves Agid [France]Compulsions, Parkinson et stimulation
000D31 Stéphane Thobois [France] ; Maria-Joao Ribeiro [France] ; Ebba Lohmann [France] ; Alexandra Dürr [France] ; Pierre Pollak [France] ; Olivier Rascol [France] ; Stéphane Guillouet [France] ; Elizabeth Chapoy [France] ; Nicolas Costes [France] ; Yves Agid [France] ; Philippe Remy [France] ; Alexis Brice [France] ; Emmanuel Broussolle [France]Young-onset Parkinson disease with and without parkin gene mutations: A fluorodopa F 18 positron emission tomography study
000D40 Jean-Luc Houeto [France] ; Marie-Laure Welter [France] ; Paul-Boulos Bejjani [Liban] ; Sophie Tezenas Du Montcel [France] ; Anne-Marie Bonnet [France] ; Valerie Mesnage [France] ; Soledad Navarro [France] ; Bernard Pidoux [France] ; Didier Dormont [France] ; Philippe Cornu [France] ; Yves Agid [France]Subthalamic stimulation in Parkinson disease: Intraoperative predictive factors
000D52 Bechir Jarraya [France] ; Anne-Marie Bonnet [France] ; Charles Duyckaerts [France] ; Jean-Luc Houetc [France] ; Philippe Cornu [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France]Parkinson's disease, subthalamic stimulation, and selection of candidates: A pathologic study
000D53 Yves Agid [France] ; I. Arnulf [France] ; P. Bejjani [États-Unis] ; F. Bloch [France] ; A. M. Bonnet [France] ; P. Damier [France] ; B. Dubois [France] ; C. Francois [France] ; J. L. Houeto [France] ; D. Iacono [France] ; C. Karachi [France] ; V. Mesnage [France] ; O. Messouak [France] ; M. Vidailhet [France] ; M. L. Welter [France] ; J. Yelnik [France]Parkinson's disease is a neuropsychiatric disorder
000D58 Baptiste A. Faucheux [France] ; Marie-Elise Martin [France] ; Carole Beaumont [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] ; Etienne C. Hirsch [France]Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease
000D69 Jérome Yelnik [France] ; Philippe Damier ; Sophie Demeret ; David Gervais ; Eric Bardinet ; Boulos-Paul Bejjani ; Chantal Francois ; Jean-Luc Houeto ; Isabelle Arnulf ; Didier Dormont ; Damien Galanaud ; Bernard Pidoux ; Philippe Cornu ; Yves Agid [France]Localization of stimulating electrodes in patients with Parkinson disease by using a three-dimensional atlas-magnetic resonance imaging coregistration method
000D74 Mathias Pessiglione [France] ; Dominique Guehl [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] ; Jean Feger [France] ; Léon Tremblay [France]Impairment of context-adapted movement selection in a primate model of presymptomatic Parkinson's disease
000D75 Ebba Lohmann [France] ; Magali Periquet [France] ; Vincenzo Bonifati [Italie] ; Nick W. Wood [Royaume-Uni] ; Giuseppe De Michele [Italie] ; Anne-Marie Bonnet [France] ; Valérie Fraix [France] ; Emmanuel Broussolle [France] ; Martin W. I. M. Horstink [Pays-Bas] ; Marie Vidailhet [France] ; Patrice Verpillat [France] ; Thomas Gasser [Allemagne] ; David Nicholl [Royaume-Uni] ; Hélio Teive [Brésil] ; Salmo Raskin [Brésil] ; Olivier Rascol [France] ; Alain Destée [France] ; Merle Ruberg [France] ; Francesca Gasparini [France] ; Giuseppe Meco [Italie] ; Yves Agid [France] ; Alexandra Durr [France] ; Alexis Brice [France]How much phenotypic variation can be attributed to parkin genotype?
000D96 Christoph-Burkhard Lücking [France] ; Véronique Chesneau [France] ; Ebba Lohmann [France] ; Patrice Verpillat [France] ; Cyprien Dulac [France] ; Anne-Marie Bonnet [France] ; Francesca Gasparini [France] ; Yves Agid [France] ; Alexandra Dürr [France] ; Alexis Brice [France]Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease
000E45 P.-P. Michel [France] ; E.-C. Hirsch [France] ; Yves Agid [France]Maladie de Parkinson : mécanismes de la mort cellulaire
000F06 I. Arnulf [France] ; E. Konofal [France] ; M. Merino-Andreu [France] ; J. L. Houeto [France] ; V. Mesnage [France] ; M. L. Welter [France] ; L. Lacomblez [France] ; J. L. Golmard [France] ; J. P. Derenne [France] ; Yves Agid [France]Parkinson's disease and sleepiness: An integral part of PD
000F27 Baptiste A. Faucheux [France] ; Marie-Elise Martin [France] ; Carole Beaumont [France] ; Stéphane Hunot [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] ; Etienne C. Hirsch [France]Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease
000F39 A. Hartmann [France] ; A. Mouatt-Prigent [France] ; B. A. Faucheux [France] ; Yves Agid [France] ; E. C. Hirsch [France]FADD: A link between TNF family receptors and caspases in Parkinson's disease
000F40 Nina Rawal [France] ; Magali Periquet [France] ; Alexandra Dürr [France] ; Giuseppe De Michele [Italie] ; Vincenzo Bonifati [Italie] ; Helio A. Teive [Brésil] ; Salmo Raskin [Brésil] ; Joao Guimaraes [Portugal] ; Yves Agid [France] ; Alexis Brice [France]Exclusion of the Nurr1 gene in autosomal recessive Parkinson's disease
000F44 Aïcha Douhou [France] ; Thomas Debeir [France] ; Mario Gustavo Murer [Argentine] ; Louis Do [France] ; Noëlle Dufour [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Georg Andrees Bohme [France] ; Yves Agid [France] ; Rita Raisman-Vozari [France]Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice
000F57 B-P Bejjani [Liban] ; I. Arnulf [France] ; J-L Houeto [France] ; D. Milea [France] ; S. Demeret [France] ; B. Pidoux [France] ; P. Damier [France] ; P. Cornu [France] ; D. Dormont [France] ; Yves Agid [France]Concurrent excitatory and inhibitory effects of high frequency stimulation: an oculomotor study
000F58 Luc Mallet [France] ; Valérie Mesnage [France] ; Jean-Luc Houeto [France] ; Antoine Pelissolo [France] ; Jérome Yelnik [France] ; Cécile Behar [France] ; Marcella Gargiulo [France] ; Marie-Laure Welter [France] ; Anne-Marie Bonnet [France] ; Bernard Pillon [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Bernard Pidoux [France] ; Jean-Francois Allilaire [France] ; Yves Agid [France]Compulsions, Parkinson's disease, and stimulation
000F61 M. L. Welter [France] ; J. L. Houeto [France] ; S. Tezenas Du Montcel [France] ; V. Mesnage [France] ; A. M. Bonnet [France] ; B. Pillon [France] ; I. Arnulf [France] ; B. Pidoux [France] ; D. Dormont [France] ; P. Cornu [France] ; Yves Agid [France]Clinical predictive factors of subthalamic stimulation in Parkinson's disease
000F68 J. L. Houeto [France] ; V. Mesnage [France] ; L. Mallet [France] ; B. Pillon [France] ; M. Gargiulo [France] ; S. Tezenas Du Moncel [France] ; A. M. Bonnet [France] ; B. Pidoux [France] ; D. Dormont [France] ; P. Cornu [France] ; Yves Agid [France] ; R. G. Brown [Royaume-Uni]Behavioural disorders, Parkinson's disease and subthalamic stimulation. Commentary
000F70 Claire Borie [France] ; Francesca Gasparini [France] ; Patrice Verpillat [France] ; Anne-Marie Bonnet [France] ; Yves Agid [France] ; Gilles Hetet [France] ; Alexis Brice [France] ; Alexandra Dürr [France] ; Bernard Grandchamp [France]Association study between iron-related genes polymorphisms and Parkinson's disease
000F76 B. P. Bejjani [Liban] ; J. L. Houeto [France] ; M. Hariz [Suède] ; J. Yelnik [France] ; V. Mesnage [France] ; A. M. Bonnet [France] ; B. Pidoux [France] ; D. Dormont [France] ; P. Cornu [France] ; Yves Agid [France]Aggressive behavior induced by intraoperative stimulation in the triangle of Sano
001021 Yves Agid [France] ; H. Dechy ; A. Destee ; P. Hinault ; E. Broussolle ; T. H. DechyAttitude pratique face aux complications de la L-dopathérapie chez les patients parkinsoniens fluctuants
001025 Philippe Damier [France] ; Jean-Luc Houeto [France] ; Boulos-Paul Bejjani [Liban] ; Isabelle Arnulf [France] ; Anne-Marie Bonnet [France] ; Malika Miloudy [France] ; Yves Agid [France]The role of the pallidum in Parkinson's disease: Gait lessons from pallidal stimulation
001036 Marie-Paule Muriel [France] ; Yves Agid [France] ; Etienne Hirsch [France]Plasticity of afferent fibers to striatal neurons bearing D1 dopamine receptors in Parkinson's disease
001040 Magali Periquet [France] ; Christoph B. Lücking [France] ; Jenny R. Vaughan [Royaume-Uni] ; Vincenzo Bonifati [Italie] ; Alexandra Dürr [France] ; Giuseppe De Michele [Italie] ; Martin W. Horstink [Pays-Bas] ; Matt Farrer [États-Unis] ; Sergei N. Illarioshkin [France] ; Pierre Pollak [France] ; Michel Borg [France] ; Christine Brefel-Courbon [Pays-Bas] ; Patrice Denefle [Allemagne] ; Giuseppe Meco [Italie] ; Thomas Gasser ; Monique M. B. Breteler ; Nick W. Wood [Royaume-Uni] ; Yves Agid [France] ; Alexis Brice [France]Origin of the mutations in the parkin gene in Europe: Exon rearrangements are independent recurrent events, whereas point mutations may result from founder effects
001050 Yves Agid [France]Levodopa: Is toxicity a myth?
001052 Andreas Hartmann [France] ; Patrick P. Michel [France] ; Jean-Denis Troadec [France] ; Annick Mouatt-Prigent [France] ; Baptiste A. Faucheux [France] ; Merle Ruberg [France] ; Yves Agid [France] ; Etienne C. Hirsch [France]Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
001064 O. Rascol [France] ; I. Arnulf [France] ; H. Peyro-Saint Paul [France] ; C. Brefel-Courbon [France] ; M. Vidailhet [France] ; C. Thalamas [France] ; A. M. Bonnet [France] ; S. Descombes [France] ; B. Bejjani [France] ; N. Fabre [France] ; J. L. Montastruc [France] ; Yves Agid [France]Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
001078 S. Descombes [France] ; A. M. Bonnet [France] ; U. E. Gasser [Suisse] ; C. Thalamas [France] ; J. Dingemanse [Suisse] ; I. Arnulf [France] ; M. P. Bareille [France] ; Yves Agid [France] ; O. Rascol [France]Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease
001087 Hélène Turmel [France] ; Andreas Hartmann [France] ; Karine Parain [France] ; Aicha Doubou [France] ; Anu Srinivasan [États-Unis] ; Yves Agid [France] ; Etienne C. Hirsch [France]Caspase-3 activation in 1 -methyl-4-phenyl- 1, 2,3,6-tetrahydropyridine (MPTP)-treated mice
001109 Yves Agid [France]Une façon d'examiner un patient parkinsonien
001180 J. L. Houeto [France] ; P. Damier [France] ; P. B. Bejjani [France] ; C. Staedler [France] ; A. M. Bonnet [France] ; I. Arnulf [France] ; B. Pidoux [France] ; D. Dormont [France] ; P. Cornu [France] ; Yves Agid [France]Subthalamic stimulation in Parkinson disease : A multidisciplinary approach
001191 B. Pillon [France] ; C. Ardouin [France] ; P. Damier [France] ; P. Krack [France] ; J. L. Houeto [France] ; H. Klinger [France] ; A. M. Bonnet [France] ; P. Pollak [France] ; A. L. Benabid [France] ; Yves Agid [France]Neuropsychological changes between "off" and "on" STN or GPi stimulation in parkinson's disease
001194 Etienne C. Hirsch [France] ; Céline Perier [France] ; Gaël Orieux [France] ; Chantal Francois [France] ; Jean Feger [France] ; Jérome Yelnik [France] ; Miquel Vila [France] ; Richard Levy [France] ; Eduardo S. Tolosa [Espagne] ; Concepcio Marin [Espagne] ; M. Trinidad Herrero [Espagne] ; José A. Obeso [Espagne] ; Yves Agid [France]Metabolic effects of nigrostriatal denervation in basal ganglia
001195 G. Orieux [France] ; C. Francois [France] ; J. Feger [France] ; J. Yelnik [France] ; M. Vila [France] ; M. Ruberg [France] ; Yves Agid [France] ; E. C. Hirsch [France]Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease
001200 B.-P. Bejjani [France, Liban] ; I. Arnulf [France] ; S. Demeret [France] ; P. Damier [France] ; A.-M. Bonnet [France] ; J.-L. Houeto [France] ; Yves Agid [France]Levodopa-induced dyskinesias in Parkinson's disease : Is sensitization reversible?
001203 Boulos Paul Bejjani [France] ; Isabelle Arnulf [France] ; Marie Vidailhet [France] ; Bernard Pidoux [France] ; Philippe Damier [France] ; Savvas Papadopoulos [France] ; Anne-Marie Bonnet [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Yves Agid [France]Irregular jerky tremor, myoclonus, and thalamus : A study using low-frequency stimulation
001204 C. Perier [France] ; Yves Agid [France] ; E. C. Hirsch [France] ; J. Feger [France]Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion
001207 I. Arnulf [France] ; B. P. Bejjani [France] ; L. Garma [France] ; A. M. Bonnet [France] ; J. L. Houeto [France] ; P. Damier [France] ; J. P. Derenne [France] ; Yves Agid [France]Improvement of sleep architecture in PD with subthalamic nucleus stimulation
001208 S. Rivaud-Pechoux [France] ; A.-I. Vermersch [France] ; B. Gaymard [Allemagne] ; C. J. Ploner [Allemagne] ; B. P. Bejjani [Allemagne] ; P. Damier [Allemagne] ; S. Demeret [Allemagne] ; Yves Agid [France] ; C. Pierrot-Deseilligny [Allemagne]Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulation
001210 I. Arnulf [France] ; A.-M. Bonnet [France] ; P. Damier [France] ; B.-P. Bejjani [France] ; D. Seilhean [France] ; J.-P. Derenne [France] ; Yves Agid [France]Hallucinations, REM sleep, and Parkinson's disease : A medical hypothesis
001213 J. Yelnik [France] ; P. Damier [France] ; B. P. Bejjani [France] ; C. Francois [France] ; D. Gervais [France] ; D. Dormont [France] ; I. Arnulf [France] ; A. M. Bonnet [France] ; P. Cornu [France] ; B. Pidoux [France] ; Yves Agid [France]Functional mapping of the human globus pallidus: Contrasting effect of stimulation in the internal and external pallidum in Parkinson's disease
001214 C. Perier [France] ; M. Vila [France] ; J. Feger [France] ; Yves Agid [France] ; E. C. Hirsch [France]Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats
001217 J. L. Houeto [France] ; P. B. Bejjani [France] ; P. Damier [France] ; C. Staedler [France] ; A. M. Bonnet [France] ; B. Pidoux [France] ; D. Dormont [France] ; P. Cornu [France] ; Yves Agid [Liban]Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD
001219 Pierre Dubus [France] ; Baptiste Faucheux [France] ; Florence Boissiere [France] ; Alexis Groppi [France] ; Claude Vital [France] ; T. Anne Vital [France] ; Yves Agid [France] ; Etienne C. Hirsch [France] ; Jean Philippe Merlio [France]Expression of Trk isoforms in brain regions and in the striatum of patients with Alzheimer's disease
001235 W.-J. Gu [France] ; N. Abbas [France] ; M. Z. Lagunes [France] ; A. Parent [France] ; L. Pradier [France] ; G. A. Bohme [France] ; Yves Agid [France] ; E. C. Hirsch [France] ; R. Raisman-Vozari [France] ; A. Brice [France]Cloning of rat parkin cDNA and distribution of parkin in rat brain
001238 B.-P. Bejjani [France, Liban] ; D. Dormont ; B. Pidoux ; J. Yelnik ; P. Damier ; I. Arnulf ; A.-M. Bonnet ; C. Marsault ; Yves Agid [France] ; J. Philippon ; P. CornuBilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance
001239 B.-P. Bejjani [France, Liban] ; D. Gervais [France] ; I. Arnulf [France] ; S. Papadopoulos [France] ; S. Demeret [France] ; A.-M. Bonnet [France] ; P. Cornu [France] ; P. Damier [France] ; Yves Agid [France]Axial parkinsonian symptoms can be improved : The role of levodopa and bilateral subthalamic stimulation
001240 C. B. Lücking [France] ; A. Dürr [France] ; V. Bonifati [Italie] ; J. Vaughan [Royaume-Uni] ; G. De Michele [Italie] ; T. Gasser [Allemagne] ; B. S. Harhangi [Pays-Bas] ; G. Meco [Italie] ; P. Denefle [France] ; N. W. Wood [Royaume-Uni] ; Yves Agid [France] ; A. Brice [France]Association between early-onset Parkinson's disease and mutations in the Parkin gene
001245 G. Ransmayr [Autriche] ; B. Faucheux [France] ; C. Nowakowski [Autriche] ; N. Kubis [France] ; S. Federspiel [Autriche] ; W. Kaufmann [Autriche] ; D. Henin [France] ; J.-J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France]Age-related changes of neuronal counts in the human pedunculopontine nucleus
001277 D. Brassat [France] ; A. Durr [France] ; Yves Agid [France] ; A. Brice [France]Génétique de la maladie de Parkinson
001287 F. Durif [France] ; M. Vidailhet [France] ; B. Debilly [France] ; Yves Agid [France]Worsening of levodopa-induced dyskinesias by motor and mental tasks
001291 B.-P. Bejjani [France] ; P. Damier [France] ; I. Arnulf [France] ; L. Thivard [France] ; A.-M. Bonnet [France] ; D. Dormont [France] ; P. Cornu [France] ; B. Pidoux [France] ; Y. Samson [France] ; Yves Agid [France]Transient acute depression induced by high-frequency deep-brain stimulation
001294 P. Damier [France, États-Unis] ; E. C. Hirsch [France] ; Yves Agid [France] ; A. M. Graybiel [États-Unis]The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease
001295 P. Damier [France, États-Unis] ; E. C. Hirsch [France] ; Yves Agid [France] ; A. M. Graybiel [États-Unis]The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D28K immunohistochemistry
001297 M. Vidailhet [France] ; A. M. Bonnet [France] ; R. Marconi [France] ; F. Durif [France] ; Yves Agid [France]The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease
001302 M. Vila [France] ; C. Marin [Espagne] ; M. Ruberg [France] ; A. Jimenez [Espagne] ; R. Raisman-Vozari [France] ; Yves Agid [France] ; E. Tolosa [Espagne] ; E. C. Hirsch [France]Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia
001307 K. Parain [France] ; M. G. Murer [France] ; QIAO YAN [États-Unis] ; B. Faucheux [France] ; Yves Agid [France] ; E. Hirsch [France] ; R. Raisman-Vozari [France]Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra
001314 Yves Agid [France]Parkinson's disease or Parkinson's diseases ?
001325 M.-P. Muriel [France] ; V. Bernard [France] ; A. I. Levey [États-Unis] ; O. Laribi [France] ; D. N. Abrous [France] ; Yves Agid [France] ; B. Bloch [France] ; E. C. Hirsch [France]Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease
001348 P. Damier [France] ; C. Jaillon [France] ; I. Clavier [France] ; I. Arnulf [France] ; A.-M. Bonnet [France] ; B.-P. Bejjani [France] ; Yves Agid [France]Dyskinesias assessment in phase II studies
001356 N. Sabbagh [France] ; A. Brice [France] ; D. Marez [France] ; A. Dürr [France] ; M. Legrand [France] ; J.-M. Lo Guidice [France] ; A. Destee [France] ; Yves Agid [France] ; F. Broly [France]CYP2D6 polymorphism and Parkinson's disease susceptibility
001358 B. A. Faucheux [France] ; A.-M. Bonnet [France] ; Yves Agid [France] ; E. C. Hirsch [France]Blood vessels change in the mesencephalon of patients with Parkinson's disease
001359 C. Ardouin [France] ; B. Pillon [France] ; E. Peiffer [France] ; P. Bejjani [France] ; P. Limousin [France] ; P. Damier [France] ; I. Arnulf [France] ; A. L. Benabid [France] ; Yves Agid [France] ; P. Pollak [France]Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions : A consecutive series of 62 patients
001364 P. P. Michel [France] ; M. Marien [France] ; M. Ruberg [France] ; F. Colpaert [France] ; Yves Agid [France]Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes
001365 M. A. Bedard [Canada] ; B. Pillon [France] ; B. Dubois [France] ; N. Duchesne [Canada] ; H. Masson [Canada] ; Yves Agid [France]Acute and long-term administration of anticholinergics in Parkinson's disease : Specific effects on the subcortico-frontal syndrome
001370 N. Abbas [France] ; C. B. Lücking [France] ; S. Ricard [France] ; A. Dürr [France] ; V. Bonifati [Italie] ; G. De Michele [Italie] ; S. Bouley [France] ; J. R. Vaughan [Royaume-Uni] ; T. Gasser [Allemagne] ; R. Marconi [Italie] ; E. Broussolle [France] ; C. Brefel-Courbon [France] ; B. S. Harhangi [Pays-Bas] ; B. A. Oostra [Pays-Bas] ; E. Fabrizio [Italie] ; G. A. Böhme [France] ; L. Pradier [France] ; N. W. Wood [Royaume-Uni] ; A. Filla [Italie] ; G. Meco [Italie] ; P. Denefle [France] ; Yves Agid [France] ; A. Brice [France]A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe
001399 M. Vidailhet [France] ; A.-M. Bonnet [France] ; Yves Agid [France]Critères cliniques de diagnostic des atrophies multi-systématisées
001408 S. Benisty [France] ; F. Boissiere [France] ; B. Faucheux [France] ; Yves Agid [France] ; E. C. Hirsch [France]trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients : An in situ hybridization study
001409 J. Villares [France, Brésil] ; B. Faucheux [France] ; M. T. Herrero [Espagne] ; J. A. Obeso [Espagne] ; C. Duyckaerts [France] ; J.-J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France][125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys
001415 J. Vaughan [Royaume-Uni] ; A. Durr [France] ; J. Tassin [France] ; B. Bereznai [Allemagne] ; T. Gasset [Allemagne] ; V. Bonifati [Italie] ; G. De Michele [Italie] ; E. Fabrizio [Italie] ; G. Volpe [Italie] ; O. Bandmann [Royaume-Uni] ; W. G. Johnson [Pays-Bas] ; L. I. Golbe [Pays-Bas] ; M. Breteler [Pays-Bas] ; G. Meco [Italie] ; Yves Agid [France] ; A. Brice [France] ; C. D. Marsden [Royaume-Uni] ; N. W. Wood [Royaume-Uni]The α-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease : A study of 230 European cases
001420 J. R. Vaughan [Royaume-Uni] ; M. J. Farrer [États-Unis] ; Z. K. Wszolek [États-Unis] ; T. Gasser [Allemagne] ; A. Durr [France] ; Yves Agid [France] ; V. Bonifati [Italie] ; G. Demichele [Italie] ; G. Volpe [Italie] ; S. Lincoln [États-Unis] ; M. Breteler [Pays-Bas] ; G. Meco [Italie] ; A. Brice [France] ; C. D. Marsden [Royaume-Uni] ; J. Hardy [États-Unis] ; N. W. Wood [Royaume-Uni]Sequencing of the α-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations
001427 S. Pol [France] ; M. Vidailhet [France] ; S. Meunier [France] ; D. Mazevet [France] ; Yves Agid [France] ; E. Pierrot-Deseilligny [France]Overactivity of cervical premotor neurons in Parkinson's disease
001439 Yves Agid [France]Levodopa : Is toxicity a myth?
001460 B.-P. Bejjani [France] ; P. Damier [France] ; I. Arnulf [France] ; S. Papadopoulos [France] ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; Yves Agid [France] ; B. Pidoux [France] ; P. Cornu [France] ; D. Dormont [France] ; C. Marsault [France]Deep brain stimulation in Parkinson's disease : Opposite effects of stimulation in the pallidum
001463 M. G. Murer [France] ; G. Dziewczapolski [Argentine] ; L. B. Menalled [Argentine] ; M. C. Garcia [Argentine] ; Yves Agid [France] ; O. Gershanik [Argentine] ; R. Raisman-Vozari [France]Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions
001464 J. Tassin [France] ; A. Dürr [France] ; T. De Broucker [France] ; N. Abbas [France] ; V. Bonifati [Italie] ; G. De Michele [Italie] ; A.-M. Bonnet [France] ; E. Broussolle [France] ; P. Pollak [France] ; M. Vidailhet [France] ; M. De Mari [Italie] ; R. Marconi [Italie] ; S. Medjbeur [France] ; A. Filla [Italie] ; G. Meco [Italie] ; Yves Agid [France] ; A. Brice [France]Chromosome 6-linked autosomal recessive early-onset parkinsonism: Linkage in European and Algerian families, extension of the clinical spectrum, and evidence of a small homozygous deletion in one family
001466 M.-A. Bedard [Canada] ; F. El Massioui [France] ; C. Malapani [France] ; B. Dubois [France] ; B. Pillon [France] ; B. Renault [France] ; Yves Agid [France]Attentional deficits in Parkinson's disease : Partial reversibility with naphtoxazine (SDZ NVI-085), a selective noradrenergic α1 agonist
001468 I. Litvan [États-Unis] ; A. Macintyre [États-Unis] ; C. G. Goetz [États-Unis] ; G. K. Wenning [Royaume-Uni] ; K. Jellinger [Autriche] ; M. Verny [France] ; J. J. Bartko [États-Unis] ; Joseph Jankovic [États-Unis] ; A. Mckee [États-Unis] ; J. P. Brandel [France] ; K. R. Chaudhuri [Royaume-Uni] ; E. C. Lai [États-Unis] ; L. D'Olhaberriague [États-Unis] ; R. K. B. Pearce [Royaume-Uni] ; Yves Agid [France]Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies : A clinicopathologic study
001515 M. Ruberg [France] ; V. France-Lanord [France] ; B. Brugg [France] ; N. Lambeng [France] ; P. P. Michel [France] ; P. Anglade [France] ; S. Hunot [France] ; P. Damier [France] ; B. Faucheux [France] ; E. Hirsch [France] ; Yves Agid [France]La mort neuronale par apoptose dans la maladie de Parkinson
001539 I. Litvan [États-Unis] ; C. G. Goetz [États-Unis] ; Joseph Jankovic [États-Unis] ; G. K. Wenning [Royaume-Uni] ; V. Booth [États-Unis] ; J. J. Bartko [États-Unis] ; A. Mckee [États-Unis] ; K. Jellinger [Autriche] ; E. C. Lai [États-Unis] ; J.-P. Brandel [France] ; M. Verny [France] ; K. R. Chaudhuri [Royaume-Uni] ; R. K. B. Pearce [Royaume-Uni] ; Yves Agid [France]What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study
001542 A. M. Bonnet [France] ; J. Pichon [France] ; M. Vidailhet [France] ; N. Gouider-Khouja [France] ; G. Robain [France] ; M. Perrigot [France] ; Yves Agid [France]Urinary disturbances in striatonigral degeneration and Parkinson's disease: Clinical and urodynamic aspects
001543 Yves Agid [France] ; A. Destee ; F. Durif ; J.-L. Montastruc ; P. PollakTolcapone, bromocriptine, and Parkinson's disease
001547 B. A. Faucheux [France] ; J. J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France]The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease
001553 P. P. Michel [France] ; M. Ruberg [France] ; Yves Agid [France]Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside
001554 R. Levy [France] ; L.-N. Hazrati [Canada] ; M.-T. Herrero [France, Espagne] ; M. Vila [France] ; O.-K. Hassani [France] ; M. Mouroux [France] ; M. Ruberg [France] ; H. Asensi [Espagne] ; Yves Agid [France] ; J. Feger [France] ; J. A. Obeso [Espagne] ; A. Parent [Canada] ; E. C. Hirsch [France]Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states
001559 B. Bejjani [France] ; P. Damier [France] ; I. Arnulf [France] ; A. M. Bonnet [France] ; M. Vidailhet [France] ; D. Dormont [France] ; B. Pidoux [France] ; P. Cornu [France] ; C. Marsault [France] ; Yves Agid [France]Pallidal stimulation for Parkinson's disease : Two targets?
001563 V. France-Lanord [France] ; B. Brugg [France] ; P. P. Michel [France] ; Yves Agid [France] ; M. Ruberg [France]Mitochondrial free radical signal in ceramide-dependent apoptosis : A putative mechanism for neuronal death in Parkinson's disease
001567 F. Durif [France] ; M. Vidailhet [France] ; F. Assal [France] ; C. Roche [France] ; A. M. Bonnet [France] ; Yves Agid [France]Low-dose clozapine improves dyskinesias in Parkinson's disease
001570 M. Ruberg [France] ; B. Brugg [France] ; A. Prigent [France] ; E. Hirsch [France] ; A. Brice [France] ; Yves Agid [France]Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis?
001578 S. Vyas [France] ; F. Javoy-Agid [France] ; M.-T. Herrero [Espagne] ; O. Strada [France] ; F. Boissiere [France] ; U. Hibner [France] ; Yves Agid [France]Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders
001595 C. Adelbrecht [France] ; M. G. Murer [France] ; I. Lauritzen [France] ; F. Lesage [France] ; M. Ladzunski [France] ; Yves Agid [France] ; R. Raisman-Vozari [France]An immunocytochemical study of a G-protein-gated inward rectifier K+ channel (GIRK2) in the weaver mouse mesencephalon
001598 I. Litvan [États-Unis] ; Yves Agid [France] ; C. Goetz [États-Unis] ; Joseph Jankovic [États-Unis] ; G. K. Wenning [Royaume-Uni] ; J. P. Brandel [France] ; E. C. Lai [États-Unis] ; M. Verny [France] ; K. Ray-Chaudhuri [Royaume-Uni] ; A. Mckee [États-Unis] ; K. Jellinger [Autriche] ; R. K. B. Pearce [Royaume-Uni] ; J. J. Bartko [États-Unis]Accuracy of the clinical diagnosis of corticobasal degeneration : A clinicopathologic study
001599 G. Dziewczapolski [Argentine] ; G. Murer [France] ; Yves Agid [France] ; O. S. Gershanik [Argentine] ; R. Raisman-Vozari [France]Absence of neurotoxicity of chronic L-DOPA in 6-hydroxydopamine-lesioned rats
001633 J. Guridi [Espagne] ; M. T. Herrero ; M. R. Luquin ; J. Guillen ; M. Ruberg ; J. Laguna ; M. Vila ; F. Javoy-Agid ; Yves Agid [France] ; E. Hirsch ; J. A. ObesoSubthalamotomy in parkinsonian monkeys : Behavioural and biochemical analysis
001640 S. Hunot [France] ; F. Boissiere [France] ; B. Faucheux [France] ; B. Brugg [France] ; A. Mouatt-Prigent [France] ; Yves Agid [France] ; E. C. Hirsch [France]Nitric oxide synthase and neuronal vulnerability in Parkinson's disease
001644 M. Vila [France] ; R. Levy [France] ; M.-T. Herrero ; B. Faucheux [France] ; J. A. Obeso [France] ; Yves Agid [France] ; E. C. HirschMetabolic activity of the basal ganglia in Parkinsonian syndrome in human and non-human primates : A cytochrome oxidase histochemistry study
001648 A. Mouatt-Prigent [France] ; J. O. Karlsson ; Yves Agid [France] ; E. C. Hirsch [France]Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon : A role in nerve cell death ?
001649 A. F. Carpentier [France] ; A. M. Bonnet [France] ; M. Vidailhet [France] ; Yves Agid [France]Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease
001652 S. Hunot [France] ; V. Bernard [France] ; B. Faucheux [France] ; F. Boissiere [France] ; E. Leguern [France] ; C. Brana [France] ; P. P. Gautris [France] ; J. Guerin [France] ; B. Bloch [France] ; Yves Agid [France] ; E. C. Hirsch [France]Glial cell line-derived neurotrophic factor (GDNF) gene expression in the human brain : a post mortem in situ hybridization study with special reference to Parkinson's disease
001654 M. T. Herrero [Espagne] ; S. J. Augood [Royaume-Uni] ; H. Asensi [Espagne] ; E. C. Hirsch [France] ; Yves Agid [France] ; J. A. Obeso [Espagne] ; P. C. Emson [Royaume-Uni]Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys
001655 C. Adelbrecht [France] ; Yves Agid [France] ; R. Raisman-Vozari [France]Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area
001657 V. Blanchard [France] ; P. Anglade [France] ; G. Dziewczapolski ; M. Savasta [France] ; Yves Agid [France] ; R. Raisman-Vozari [France]Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra
001658 P. Damier [France] ; A. Kastner [France] ; Yves Agid [France] ; E. C. Hirsch [France]Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease ?
001661 M. Vila [France] ; M. T. Herrero ; R. Levy [France] ; B. Faucheux [France] ; M. Ruberg [France] ; J. Guillen ; M. R. Luquin ; J. Guridi ; F. Javoy-Agid [France] ; Yves Agid [France] ; J. A. Obeso ; E. C. Hirsch [France]Consequences of nigrostriatal denervation on the γ-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes
001664 P. P. Michel [France] ; Yves Agid [France]Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons
001666 B. Brugg [France] ; P. P. Michel ; Yves Agid [France] ; M. RubergCeramide induces apoptosis in cultured mesencephalic neurons
001690 Yves Agid [France] ; L. Montagnier ; M. Bourel ; G. Serratrice ; R. Nordmann ; G. Blancher ; C. Pilet ; M.-O. Mme Rethore ; H. Lestradet ; J. Polonovski ; H. Bouissou ; P. Lefebvre ; J.-L. De GennesLe vieillissement, la maladie et la mort des cellules nerveuses. Discussion
001704 R. Levy [France] ; M. Vila [France] ; M.-T. Herrero ; B. Faucheux [France] ; Yves Agid [France] ; E. C. Hirsch [France]Striatal expression of substance P and methionin-enkephalin genes in patients with Parkinson's disease
001708 F. Thibaut [France] ; B. A. Faucheux [France] ; J. Marquez [France] ; J. Villares [France] ; J. F. Menard [France] ; Yves Agid [France] ; E. C. Hirsch [France]Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease : a postmortem study using tritiated tetrabenazine
001712 P. Anglade [France] ; S. Tsuji [France] ; F. Javoy-Agid [France] ; Yves Agid [France] ; E. C. Hirsch [France]Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease
001716 B. Pillon [France] ; N. Gouider-Khouja ; B. Deweer ; M. Vidailhet ; C. Malapani ; B. Dubois ; Yves Agid [France]Neuropsychological pattern of striatonigral degeneration : comparison with Parkinson's disease and progressive supranuclear palsy
001722 V. Blanchard [France] ; M. Chritin ; SHEELA VYAS [France] ; M. Savasta ; C. Feuerstein ; Yves Agid [France] ; F. Javoy-Agid [France] ; R. Raisman-Vozari [France]Long-term induction of tyrosine hydroxylase expression : compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain
001723 F. Durif [France] ; M. Vidailhet ; A. M. Bonnet ; J. Blin ; Yves Agid [France]Levodopa-induced dyskinesias are improved by fluoxetine
001729 M.-T. Herrero [Espagne] ; S. J. Augood ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; M. R. Luquin [Espagne] ; Yves Agid [France] ; J. A. Obeso [Espagne] ; P. C. EmsonEffects of L-DOPA on preproenkephalin and preprotackykinin gene expression in the MPTP-treated monkey striatum
001731 M. Ruberg [France] ; D. Scherman [France] ; F. Javoy-Agid [France] ; Yves Agid [France]Dopamine denervation, age on onset, and Parkinson's disease
001732 J. Blin [France] ; P. Mazetti ; B. Mazoyer [France] ; S. Rivaud ; S. Ben Ayed [France] ; C. Malapani ; B. Pillon ; Yves Agid [France]Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy ?
001739 B. A. Faucheux [France] ; M. T. Herrero ; J. Villares [France] ; R. Levy [France] ; F. Javoy-Agid [France] ; J. A. Obeso ; J. J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France]Autoradiographic localization and density of[125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys
001745 A. M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France]A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists : application to pergolide and bromocriptine
001746 N. Gouider-Khouja [France] ; M. Vidailhet [France] ; A.-M. Bonnet [France] ; J. Pichon [France] ; Yves Agid [France]"Pure" striatonigral degeneration and Parkinson's disease : a comparative clinical study
001783 S. Holemans [Belgique] ; F. Javoy-Agid [France] ; Yves Agid [France] ; F. De Paermentier ; E. C. Laterre [Belgique] ; J.-M. Maloteaux [Belgique]Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease
001785 A.-I. Vermersch [France] ; S. Rivaud ; M. Vidailhet ; A.-M. Bonet ; B. Gaymard ; Yves Agid [France] ; C. Pierrot-DeseillignySequences of memory-guided saccades in Parkinson's disease
001794 S. Lehericy [France] ; J.-P. Brandel [France] ; E. C. Hirsch [France] ; P. Anglade [France] ; J. Villares [France] ; D. Scherman [France] ; C. Duyckaerts [France] ; F. Javoy-Agid [France] ; Yves Agid [France]Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography
001796 J. Villares [France] ; O. Strada ; B. Faucheux ; F. Javoy-Agid ; Yves Agid [France] ; E. C. HirschLoss of striatal affinity NGF binding sites in progressive supranuclear palsy but not in Parkinson's disease
001797 R. Marconi [France] ; D. Lefebvre-Caparros ; A.-M. Bonnet [France] ; M. Vidailhet [France] ; B. Dubois [France] ; Yves Agid [France]Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology
001799 C. Malapani [France] ; B. Pillon ; B. Dubois ; Yves Agid [France]Impaired simultaneous cognitive task performance in Parkinson's disease : a dopamine-related dysfunction
001800 G. Boka [France] ; P. Anglade [France] ; D. Wallach ; F. Javoy-Agid [France] ; Yves Agid [France] ; E. C. Hirsch [France]Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
001803 M. Vidailhet [France] ; S. Rivaud ; N. Gouider-Khouja ; B. Pillon ; A.-M. Bonnet ; B. Gaymard ; Yves Agid [France] ; C. Pierrot-DesellignyEye movements in parkinsonian syndromes
001805 A. Mouatt-Prigent [France] ; Yves Agid [France] ; E. C. HirschDoes the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease ?
001808 A. Kastner [France] ; M. T. Herrero [France] ; E. C. Hirsch [France] ; J. Guillen ; M. R. Luquin ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France]Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys : effect of levodopa and GM1 ganglioside therpay
001813 B. Pillon [France] ; B. Deweer ; A. Michon ; C. Malapani ; Yves Agid [France] ; B. DuboisAre explicit memory disorders of progressive supranuclear palsy related to damage to striatofrontal circuits ? : Comparison with Alzheimer's, Parkinson's, and Huntington's diseases
001830 Yves Agid [France]Mécanisme de la mort cellulaire dans les affections neurodégénératives : à propos de la maladie de Parkinson
001871 O. Strada [France] ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; C. Duyckaerts [France] ; J.-J. Hauw [France] ; Yves Agid [France]Low affinity nerve growth factor receptor, adrenal transplant and Parkinson's disease
001877 P. Damier [France] ; E. C. Hirsch ; P. Zhang ; Yves Agid [France] ; F. Javoy-AgidGlutathione peroxidase, glial cells and Parkinson's disease
001878 M.-T. Herrero [France] ; A. Kastner [France] ; I. Perez-Otano ; E. C. Hirsch [France] ; M.-R. Luquin ; F. Javoy-Agid [France] ; J. Del Rio ; J. A. Obeso ; Yves Agid [France]Gangliosides and parkinsonism
001879 M. T. Herrero [France] ; I. Perez-Otano ; C. Oset ; A. Kastner [France] ; E. C. Hirsch [France] ; Yves Agid [France] ; M. R. Luquin ; J. A. Obeso ; J. Del RioGM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys
001880 B. Pillon [France] ; B. Deweer ; Yves Agid [France] ; B. DuboisExplicit memory in Alzheimer's, Huntington's, and Parkinson's diseasees
001888 M. T. Herrero [France] ; E. C. Hirsch [France] ; A. Kastner [France] ; M. Ruberg [France] ; M. R. Luquin ; J. Laguna ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France]Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP ?
001889 B. A. Faucheux [France] ; E. C. Hirsch [France] ; J. Villares [France] ; F. Selimi [France] ; A. Mouatt-Prigent [France] ; F. Javoy-Agid [France] ; J. J. Hauw [France] ; Yves Agid [France]Distribution of 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease
001890 M. T. Herrero [France] ; E. C. Hirsch [France] ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France]Differential vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of dopaminergic and cholinergic neurons in the monkey mesopontine tegmentum
001892 P. Vermersch [France] ; A. Delacourte [France] ; F. Javoy-Agid [France] ; J.-J. Hauw [France] ; Yves Agid [France]Dementia in Parkinson's disease : biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins
001895 J. Villares [France] ; B. Faucheux ; O. Strada ; E. C. Hirsch ; Yves Agid [France] ; F. Javoy-AgidAutoradiographic study of [125I]epidermal growth factor-binding sites in the mesencephalon of control and parkinsonian brains post-mortem
001896 Yves Agid [France] ; M. Ruberg ; F. Javoy-Agid ; E. Hirsch ; R. Raisman-Vozari ; S. Vyas ; B. Faucheux ; P. Michel ; A. Kastner ; V. Blanchard ; P. Damier ; J. Villares ; PING ZHANGAre dopaminergic neurons selectively vulnerable to Parkinson's disease ?
001945 P. P. Michel [France] ; S. Vyas ; Yves Agid [France]Toxic effects of iron for cultured mesencephalic dopaminergic neurons derived from rat embryonic brains
001947 P. P. Michel [France] ; Yves Agid [France]The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures
001954 A. Kastner [France] ; E. C. Hirsch ; O. Lejeune ; F. Javoy-Agid ; O. Rascol [France] ; Yves Agid [France]Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content ?
001958 E. C. Hirsch [France] ; A. Mouatt ; B. Faucheux ; A.-M. Bonnet ; F. Javoy-Agid ; A. M. Graybiel ; Yves Agid [France]Dopamine, tremor, and Parkison's disease
001997 S. Holemans [Belgique] ; F. Javoy [France] ; Yves Agid [France] ; E. C. Laterre ; J.-M. Maloteaux[3H]MK-801 binding to NMDA glutamatergic receptors in Parkinson's disease and progressive supranuclear palsy
001A01 B. Pillon ; B. Dubois ; A. Ploska ; Yves Agid [France]Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy
001A07 Yves Agid [France]Parkinson's disease : pathophysiology
001A09 E. C. Hirsch [France] ; J.-P. Brandel ; P. Galle ; F. Javoy-Agid ; Yves Agid [France]Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease : an X-ray microanalysis
001A13 J. Blin [France] ; B. Dubois ; A. M. Bonnet ; M. Vidailhet ; M. Brandabur ; Yves Agid [France]Does ageing aggravate Parkinsonian disability ?
001A49 S. Dumas ; F. Javoy-Agid ; E. Hirsch ; Yves Agid [France] ; J. MalletTyrosine hydroxylase gene expression in human ventral mesencephalon : detection of tyrosine hydroxylase messenger RNA in neurites
001A54 R. Raisman-Vozari ; J.-A. Girault ; S. Moussaoui ; C. Feuerstein ; P. Jenner ; C. D. Marsden ; Yves Agid [France]Lack of change in triatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man
001A56 E. C. Hirsch ; C. Duyckaerts ; F. Javoy-Agid ; J.-J. Hauw ; Yves Agid [France]Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease ?
001A57 F. Javoy-Agid ; E. C. Hirsch ; S. Dumas ; C. Duyckaerts ; J. Mallet ; Yves Agid [France]Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease : an in situ hybridization study
001A58 D. T. Dexter [Royaume-Uni] ; A. Carayon ; M. Vidailhet ; M. Ruberg ; F. Agid ; Yves Agid [France] ; A. J. Lees ; F. R. Wells ; P. Jenner ; C. D. MarsdenDecreased ferritin levels in brain in Parkinson's disease
001A59 B. Dubois ; B. Pillon ; F. Lhermitte ; Yves Agid [France]Cholinergic deficiency and frontal dysfunction in Parkinson's disease
001A60 M. Ruberg ; W. Mayo ; A. Brice ; C. Duyckaerts ; J. J. Hauw ; H. Simon ; M. Lemoal ; Yves Agid [France]Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions
001A61 S. Malessa ; E. C. Hirsch ; P. Cervera ; C. Duyckaerts ; Yves Agid [France]Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes : a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration
001A63 B. Dubois ; B. Pillon ; N. Sternic ; F. Lhermitte ; Yves Agid [France]Age-induced cognitive disturbances in Parkinson's disease
001A93 D. Scherman ; C. Desnos ; F. Darchen ; P. Pollak ; F. Javoy-Agid ; Yves Agid [France]Striatal dopamine deficiency in Parkinson's disease: role of aging
001A95 E. C. Hirsch ; A. M. Graybiel ; Yves Agid [France]Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease
001A98 E. Pourcher ; A.-M. Bonnet ; J. Kefalos ; B. Dubois ; Yves Agid [France]Effects of etybenzatropine and diazepam on Levodopa-induced diphasic dyskinesias in Parkinson's disease
001A99 B. Pillon ; B. Dubois ; G. Cusimano ; A.-M. Bonnet ; F. Lhermitte ; Yves Agid [France]Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?
001B00 B. Pillon ; B. Dubois ; A.-M. Bonnet ; M. Esteguy ; J. Guimaraes ; J.-M. Vigouret ; F. Lhermitte ; Yves Agid [France]Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test
001B22 J. Epelbaum ; F. Javoy-Agid ; A. Enjalbert ; S. Krantic ; C. Kordon ; Yves Agid [France]Somatostatin concentrations and binding sites in human frontal cortex are differentially affected in Parkinson's disease associated dementia and in progressive supranuclear palsy
001B23 B. Dubois ; B. Pillon ; F. Legault ; Yves Agid [France] ; F. LhermitteSlowing of cognitive processing in progressive supranuclear palsy: a comparison with Parkinson's disease
001B24 S. Jegou ; F. Javoy-Agid ; C. Delbende ; D. Tranchand-Bunel ; D. H. Coy ; Yves Agid [France] ; H. VaudryRegional distribution of vasoactive intestinal peptide in brains from normal and parkinsonian subjects
001B28 J. Blin ; A.-M. Bonnet ; Yves Agid [France]Does levodopa aggravate Parkinson's disease ?
001B29 L. Pierot ; C. Desnos ; J. Blin ; R. Raisman ; D. Scherman ; F. Javoy-Agid ; M. Ruberg ; Yves Agid [France]D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy
001B30 E. Hirsch ; M. Ruberg ; M.-M. Portier ; M. Dardenne ; Yves Agid [France]Characterization of two antigens in parkinsonian Lewy bodies
001B52 P. Dealy-Goyet ; J.-M. Zajac ; F. Javoy-Agid ; Yves Agid [France] ; B. P. RoquesRegional distribution of μ, σ and k opioid receptors in human brains from controls and parkinsonian subjects
001B62 R. Cash ; R. Raisman ; A. Ploska ; Yves Agid [France]Dopamine D-1 receptor and cyclic AMP-dependent phosphorylation in Parkinson's disease
001B64 A.-M. Bonnet ; Y. Loria ; M.-H. Saint-Hilaire ; F. Lhermitte ; Yves Agid [France]Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?
001B65 B. Dubois ; F. Danze ; B. Pillon ; G. Cusimano ; F. Lhermitte ; Yves Agid [France]Cholinergic-dependent cognitive deficits in Parkinson's disease
001B66 A. M. Bonnet ; G. Tell ; P. J. Schechter ; J. Grove ; M. H. Saint-Hilaire ; Y. De Smet ; Yves Agid [France]Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea
001B67 J. Epelbaum ; F. Javoy-Agid ; E. Hirsch ; J. J. Hauw ; C. Kordon ; S. Krantic ; Yves Agid [France]Brain somatostatin concentrations do not decrease in progressive supranuclear palsy
001B68 M. Ruberg ; A. Villageois ; A.-M. Bonnet ; B. Pillon ; F. Rieger ; Yves Agid [France]Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems
001B73 B. Dubois ; Yves Agid [France]Les agonistes dopaminergiques dans la maladie de Parkinson
001B77 Yves Agid [France] ; H. Taquet ; F. Cesselin ; J. Epelbaum ; F. Javoy-AgidNeuropeptides and parkinson's disease
001B79 B. Pillon ; B. Dubois ; F. Lhermitte ; Yves Agid [France]Heterogeneity of cognitive impairment in progressive supranuclear palsy, Parkinson's disease, and Alzheimer's disease
001B81 B. Dubois ; B. Pillon ; H. De Saxce ; F. Lhermitte ; Yves Agid [France]Disappearance of Parkinsonian signs after spontaneous vascular ``thalamotomy''
001B96 J. C. Monfort ; F. Javoy-Agid ; J. J. Hauw ; B. Dubois ; Yves Agid [France]Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index
001C01 B. Bokobza ; M. Ruberg ; B. Scatton ; F. Javoy-Agid ; Yves Agid [France][3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy
001C02 J.-Y. Mear ; G. Barroche ; Y. De Smet ; M. Weber ; F. Lhermitte ; Yves Agid [France]Pergolide in the treatment of Parkinson's disease
001C03 D. Rougemont ; J. C. Baron ; P. Collard ; P. Bustany ; D. Comar ; Yves Agid [France]Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease
001C04 C. Llorens-Cortes ; F. Javoy-Agid ; Yves Agid [France] ; H. Taquet ; J. C. SchwartzEnkephalinergic markers in substantia nigra and caudate nucleus from Parkinsonian subjects
001C06 R. Cash ; M. Ruberg ; R. Raisman ; Yves Agid [France]Adrenergic receptors in Parkinson's disease

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024